Threshold Pharmaceuticals Inc. (THLD) belonging to the Medical sector has surged 11.48% and closed its last trading session at $0.68.
The company reported its EPS on 03/16/2017. Currently, the stock has a 1 Year Price Target of $0.7.
The consensus recommendation, according to Zacks Investment research, is 2.33. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.
The Stock had a 2.33 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2.33 and 2.33 respectively.
Threshold Pharmaceuticals Inc. on 03/16/2017 reported its EPS as $-0.08 with the analysts projecting the EPS of the stock as $-0.09. The company beat the analyst EPS Estimate with the difference of $0.01. This shows a surprise factor of 11.1%.
Many analysts have provided their estimated foresights on Threshold Pharmaceuticals Inc. Earnings, with 4 analysts believing the company would generate an Average Estimate of $-0.08.
Whereas they predicted High and Low Earnings Estimate as $-0.07 and $-0.08 respectively. While in the same Quarter Previous year, the Actual EPS was $0.86.
For the Current Quarter, the growth estimate for Threshold Pharmaceuticals Inc. is -109.3%, while for the Next Quarter the stock growth estimate is 36.4%.
The Company got Initiated by H.C. Wainwright on 5-Sep-14 to Buy.
Insider Trades for Threshold Pharmaceuticals Inc. show that the latest trade was made on 29 Feb 2016 where BIRD JEFFREY W, the Director completed a transaction type “Buy” in which 96010 shares were traded at a price of $0.
2 analysts projected Price Targets for Threshold Pharmaceuticals Inc.. The analysts believe that the company stock price could grow as high as $1. The Low Price target projection by analysts is $0.4 and the Mean Price Target is $0.7.
Threshold Pharmaceuticals Inc. (THLD) has the market capitalization of $48.7 Million. The company rocked its 52-Week High of $1.48 on Sep 6, 2016 and touched its 52-Week Low of $0.3 on May 9, 2016.
The stock has Return on Assets (ROA) of 122.8 percent. Return on Equity (ROE) stands at 157.2% and Return on Investment (ROI) of 66 percent.
The stock is currently showing YTD performance of 54.55 Percent. The company has Beta Value of 2.84 and ATR value of 0.08. The Weekly and Monthly Volatility stands at 20.07% and 11.26%.